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Abstract: Background: Timely recognition of critical congenital heart defects in neonates is eminent to
decrease the associated morbidity and mortality. Clinical symptoms are often lacking within the first few
days of life, and 30% of the patients with critical congenital heart defects leave the maternity unit without
being diagnosed. Early detection can be improved by measuring the transcutaneous oxygen saturation
within the first hours of life. Recent studies on pulse oximetry (pox)screening report a specificity of
95.5 to 100% and a sensitivity of 62–97% for detecting critical congenital heart defects in neonates when
postductal transcutaneous saturation is below 95%. Pox screening has been recommended in Switzerland
since 2005 by the Swiss Societies of Neonatology and Paediatric Cardiology. The aim of this study was to
assess the identification of critical c ongenital heart defects (CHD) through pox screening by describing
patient characteristics in screening-positive individuals. Methods and results: From January 2009 to
January 2011 all Swiss paediatric cardiologists were asked to voluntarily fill out a standardised ques-
tionnaire for each patient undergoing echocardiography on account of positive pox screening. Prenatally
diagnosed CHD were excluded from this analysis. A total of 48 questionnaires were returned. 27 neonates
(56%) had structural heart defects (true positive pox screening test results) including 24 neonates with
critical heart defects. In 21 patients (44%), cardiac anatomy was normal (false positive pox-screening
test results). In 10 out of the 21 patients, low saturation was explained by evidence of pulmonary hy-
pertension on echocardiography, with right to left shunting through a patent foramen ovale or arterial
duct. This analysis is limited by underreporting, meaning that the true number of patients detected with
pox screening in Switzerland may be higher. In addition, some Swiss maternity units do not perform
routine pox screening. Conclusion: The current practice of pox screening in Switzerland made it possible
to identify 24 neonates with critical CHD within two years. These patients were diagnosed in time and
referred for further treatment in a stable condition. The results of this study support the evidence for
the further use of pox screening for CHD in Switzerland.
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Summary
Background: Timely recognition of critical congenital 
heart defects in neonates is eminent to decrease the as-
sociated morbidity and mortality. Clinical symptoms 
are often lacking within the first few days of life, and 
30% of the patients with critical congenital heart de-
fects leave the maternity unit without being diagnosed. 
Early detection can be improved by measuring the 
transcutaneous oxygen saturation within the first 
hours of life. Recent studies on pulse oximetry (pox) 
screening report a specificity of 95.5 to 100% and a sen-
sitivity of 62–97% for detecting critical congenital 
heart defects in neonates when postductal transcuta-
neous saturation is below 95%. Pox screening has been 
recommended in Switzerland since 2005 by the Swiss 
Societies of Neonatology and Paediatric Cardiology. 
The aim of this study was to assess the identification of 
critical congenital heart defects (CHD) through pox 
screening by describing patient characteristics in 
screening-positive individuals.
Methods and results: From January 2009 to Janu-
ary 2011 all Swiss paediatric cardiologists were asked 
to voluntarily fill out a standardised questionnaire for 
each patient undergoing echocardiography on account 
of positive pox screening. Prenatally diagnosed CHD 
were excluded from this analysis. A total of 48 ques-
tionnaires were returned. 27 neonates (56%) had struc-
tural heart defects (true positive pox screening test re-
sults) including 24 neonates with critical heart defects. 
In 21 patients (44%), cardiac anatomy was normal 
(false positive pox-screening test results). In 10 out of 
the 21 patients, low saturation was explained by evi-
dence of pulmonary hypertension on echocardiogra-
phy, with right to left shunting 
through a patent foramen ovale or 
arterial duct. This analysis is lim-
ited by underreporting, meaning 
that the true number of patients 
detected with pox screening in 
Switzerland may be higher. In ad-
dition, some Swiss maternity units do not perform rou-
tine pox screening.
Conclusion: The current practice of pox screening 
in Switzerland made it possible to identify 24 neonates 
with critical CHD within two years. These patients 
were diagnosed in time and referred for further treat-
ment in a stable condition. The results of this study 
support the evidence for the further use of pox screen-
ing for CHD in Switzerland.
Key words: pulse oximetry; congenital heart defect; 
newborns
Introduction
Congenital heart defects (CHD) are the most common 
congenital defects, with a prevalence of 6 to 8 per 1000 
live births [1–2]. If there is need for early intervention, 
then the term critical CHD is used. In newborns, clini-
cal symptoms of critical CHD are often lacking within 
the first few days of life. Up to 30% of neonates with 
critical CHD leave the maternity unit undiagnosed [1]. 
These patients are at increased risk of sudden deterio-
ration following spontaneous closure of the arterial 
duct. Pulse oximetry (pox) screening consists of meas-
uring the postductal transcutaneous oxygen saturation 
within the first 24 hours of life. In patients with satu-
rations <95%, echocardiographic examination is rec-
ommended [1]. The screening is noninvasive, and ap-
propriately simple and not very expensive [5]. It has 
been shown to be effective in the detection of CHD with 
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uary 2011 questionnaires were sent out once a month 
to all the Swiss paediatric and adult cardiologists in-
volved in neonatal diagnosis of CHD. All neonates born 
as of 35 weeks of gestation with a positive pox screen-
ing test were included in the study. Patients with an 
antenatal diagnosis of CHD and patients who had ob-
vious severe postnatal symptoms of CHD were ex-
cluded from this study, because these patients would 
have been identified anyway, even in the absence of 
pox screening. The cardiologists were asked to indicate 
the patient’s age at the time of echocardiography, the 
results of the echocardiographic examination and any 
associated clinical findings which could explain a low 
oxygen saturation. Diagnoses were grouped into cate-
gories according to the intracardiac morphology and 
haemodynamics. Patients with isolated patent arterial 
duct (PDA) or patent foramen ovale (PFO) were classi-
fied as having a normal intracardiac anatomy. Congen-
ital heart defects which require surgery or catheter in-
tervention within the first months of life are called crit-
ical CHD. The times specified up until the need for 
intervention vary in recent publications between the 
first month and the first year of life [3–4] and has been 
defined for this paper at six months. Missing data were 
filled in by contacting the responsible physician di-
rectly or by analysing the patient’s notes. The study 
was approved by the local hospital’s ethics committee. 
Descriptive statistics were performed on the data using 
SPSS 16.0.2., German version for Windows. 
Results
During the study period of two years, a total of 48 ques-
tionnaires were returned from cardiologists located in 
the Zurich area (29), Aargau (11), St. Gallen (4), Lu-
zern (2), Thurgau (1) and Vaud (1). The median age at 
the time of echocardiography was the first day of life 
(range 1 to 6 days). An overview of the echocardio-
graphic findings in the 48 screening-positive patients 
is given in figure 1, and the diagnoses are listed in ta-
ble 1. 
In 22 of all 48 screening-positive patients, there 
were additional clinical findings that might have 
prompted an echocardiographic evaluation even in the 
absence of a positive pox screening result: heart mur-
mur (11), cyanosis (8), trisomy 21 (4), trisomy 13 (1), 
muscular hypotonia (1). A separate analysis was per-
formed for the 24 patients with critical CHD (table 2). 
13 of these 24 patients (54%) were asymptomatic at the 
time of pox screening.
Discussion
The present study demonstrates that, over a period of 
two years, pox screening in Switzerland allowed the 
early diagnosis of CHD in 27 neonates, including 24 neo-
nates with critical CHD. 
a specificity of 95.5 to 100% [4, 6] and a sensitivity of 
62–97% [1–2, 4, 7–8]. In 2005, it was recommended for 
all Swiss maternity units by the Swiss Societies of 
Neonatology and Paediatric Cardiology [9]. The aim of 
this study was to assess the identification of critical 
congenital heart defects (CHD) through pox screening 
by describing patient characteristics in screening-pos-
itive individuals in Switzerland.
Methods
The study was conducted as a voluntary prospective 
Swiss multi-centre survey. From January 2009 to Jan-
Table 1
Echocardiographic findings in 48 patients with positive pulse oximetry screening.
Group of diagnoses N
Critical congenital heart defects 24
 Transposition of great arteries 7
 Total anomalous pulmonary venous return 4
 Coarctation of the aorta 3
 Complete atrioventricular septal defect 3
 Double outlet right ventricle (with transposition of the great arteries) 3
 Tetralogy of Fallot 2
 Hypoplastic left heart syndrome 1
 Pulmonary atresia 1
Congenital heart defects, not critical 3
 Ventricular septal defect 2
 Pulmonary valve stenosis 1
Normal intracardiac anatomy 21
Total 48
Figure 1
Echocardiographic and clinical findings in 48 patients with a positive pulse oximetry 
screening result.
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pertension in neonates is beneficial, including in the 
absence of CHD, since it can draw attention to an un-
derlying problem like a sepsis. 
The number of neonates with critical CHD in Swit-
zerland is not known but can be estimated at approxi-
mately 200–300 over a two-year period. Many of these 
patients did not fulfil the inclusion criteria for this 
study, because they were diagnosed by routine ante-
natal ultrasound or in the context of obvious postnatal 
clinical findings [15–16]. The collected sample of 48 
positive screening test results still does not represent 
the full number of screening-positive test results ex-
pected in Switzerland during this period. This under-
reporting, which is due to a lack of cooperation on the 
part of the cardiologists involved and also to the incom-
plete notification of all the physicians engaged in the 
care and ultrasound screening of neonates, constitutes 
a weakness of the present study. Further insight into 
the topic of diagnosis and management of CHD in Swit-
zerland will only be possible with a complete dataset of 
all the neonates with CHD, including the circum-
stances of their diagnosis and data on their follow-up. 
Conclusion
Transcutaneous pulse oximetry screening is an effi-
cient way of identifying congenital heart defects at an 
early stage. A significant number of newborns with 
critical congenital heart defects that have not been de-
tected prenatally can be identified at an asymptomatic 
stage, before clinical deterioration occurs. This makes 
it possible to avoid cardiogenic shock in these patients. 
The results of this study provide further evidence of the 
usefulness of Switzerland’s current pulse oximetry 
screening policy. In order to improve morbidity and 
mortality in patients with CHD in Switzerland, an on-
going prospective registry covering all neonates with 
CHD is required. 
The list of diagnosed asymptomatic critical CHD is 
interesting and also involves acyanotic lesions such as 
coarctation of the aorta and atrioventricular septal de-
fect (table 2). Among those CHD that were positively 
screened, four were patients with total anomalous pul-
monary venous return, and all those four neonates 
were asymptomatic. These patients are good examples 
for the benefit of the pox screening because cata-
strophic cardio circulatory collapse often occurs within 
the first days of life and it is one of the most commonly 
prenatal undiagnosed CHD, because recommendations 
for heart evaluation during the morphology exam at 
20–22 weeks is directed towards visualisation of the 
4-chamber view and crossing of the great vessels, and 
this does not allow diagnosis of total anomalous pulmo-
nary venous return in the vast majority of foetuses.
Since pox screening was first described in Switzer-
land in 2005 [9], a large number of studies have been 
published on this subject. The results are summarised 
in a large meta-analysis [10] and in a scientific state-
ment by the American Heart Association and the 
American Academy of Pediatrics [4]. Pox screening has 
continuously gained acceptance in Europe and the 
United States [11]. Our small study of positive screen-
ing-test results in Switzerland further supports the 
benefit of pox screening and, today, there is no reason 
not to perform the screening in Switzerland.
The normal course of postnatal oxygen saturation 
is well known [12]: a healthy newborn at the age of two 
minutes has a mean arterial oxygen saturation of 73%, 
which rises to 95% within one hour. This process is in-
dividual and varies considerably, which explains the 
high rate of false positive pox screening test results in 
studies with screenings very soon after birth [5, 13–
14]. In our study population, 21/48 patients with a low 
saturation (positive pox screening) had a normal intra-
cardiac anatomy. Pulmonary hypertension accounts 
for at least 48% of these false positive test results in 
our study. Early detection of persistent pulmonary hy-
Table 2
Clinical findings in patients with critical congenital heart defects (n = 24). Multiple answers per patient are possible. Data are given as numbers of 
patients and percentage of the respective group.
Asymptomatic Heart murmur Cyanosis
Coarctation of the aorta  3  1 (33%) 2 1
Transposition of great arteries  7  3 (43%) 0 4
Hypoplastic left heart syndrome  1  0 1 0
Total anomalous pulmonary venous return  4  4 (100%) 0 0
Complete atrioventricular septal defect  3  3 (100%) 0 0
Double outlet right ventricle with transposition  
of the great arteries
 3  1 (33%) 1 1 
Tetralogy of Fallot  2  1 (50%) 1 0
Pulmonary atresia  1  0 0 1
Total  24 13 (54%)
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